Evaluation of the clinical value of 3D-CDFI in bladder tumor diagnose

Objective the purpose of this study is to evaluate clinical value by analyzing 3D-CDFI in bladder tumor diagnose.Methods sampling 52 focuses from 43 patients who had bladder masses from our hospital, from January 2012 to February2014, comparing diagnosis of two-dimensional(2D) ultrasonographies, 3D-CDFI, three-dimensional(3D) ultrasonographies and cystoscope to result of 3D-CDFI clinical value. Results According to pathological and cystectomy diagnosis, 48 out of 52 bladder masses were bladder tumors. Amongst 48 bladder tumors, 45 cases proved malignant(45/48) while 3 are benign; 4 out of 52 cases are non-48 bladder tumor(3 proved to be clot and 1 proved to endometriosis). Diagnose accordance rate to endometriosis: the accordance rate of result to three-dimensional ultrasound 96.15%(50/52) is higher than two-dimensional ultrasound 85.69%(43/52), P0.05, which is of statistical significance. The result to Color Doppler ultrasonography 3D-CDFI85.25%(39/48)within Bladder tumor is higher than CDFI 62.50%(30/48), P0.05, which is of statistical significance. The accordance rate of result to 3D-CDFI Staging is higher than two-dimensional ultrasound, P0.05, which is of statistical significance. Conclusion 3D-CDFI can increase the blood flow display rates of bladder tumor, and judge the depth of bladder tumor, so it is important to precise tumor diagnosis. It is feasible for clinical application for 3D-CDFI is easy to control,non-invasive, replicable, time and money saving, and acceptable to patients.